Tempus AI Surges 15% in Nasdaq Debut, Valued at $6.65 Billion
Tempus AI rose 15% in its Nasdaq debut, reaching a $6.65B valuation. The company uses AI to enhance medical test accuracy and treatment.
Sunway Healthcare and AstraZeneca Sign Landmark MOU
Sunway Healthcare and AstraZeneca signed an MOU to enhance clinical trials, research, and healthcare services in a groundbreaking partnership.